about
Seed Oil of Brucea javanica Induces Apoptotic Death of Acute Myeloid Leukemia Cells via Both the Death Receptors and the Mitochondrial-Related PathwaysGene expression profiles in acute myeloid leukemia with common translocations using SAGE.Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia.Intensive chemotherapy for acute myeloid leukemia differentially affects circulating TC1, TH1, TH17 and TREG cells.Cooperative antitumor effects of vitamin D3 derivatives and rosemary preparations in a mouse model of myeloid leukemiaPuquitinib, a novel orally available PI3Kδ inhibitor, exhibits potent antitumor efficacy against acute myeloid leukemiaAssessment of cytokine expression profile in acute myeloid leukemia patients before and after chemotherapyThe phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.Effect of conditioning regimen intensity on acute myeloid leukemia outcomes after umbilical cord blood transplantationDoes Chemotherapy Change Expression of VEGF A&C and MVD in Acute Myeloid Leukemia?Effects of cytarabine on activation of human T cells - cytarabine has concentration-dependent effects that are modulated both by valproic acid and all-trans retinoic acidDown-regulation of GPX3 is associated with favorable/intermediate karyotypes in de novo acute myeloid leukemiaPre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemia.mTOR regulates cell survival after etoposide treatment in primary AML cellsClinical significance of up-regulated ID1 expression in Chinese de novo acute myeloid leukemiaThe expression of CD56 antigen is associated with poor prognosis in patients with acute myeloid leukemia.Protein lysine acetylation in normal and leukaemic haematopoiesis: HDACs as possible therapeutic targets in adult AML.Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia.Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth.Underreporting of myeloid malignancies by United States cancer registries.Potential biomarkers for adult acute myeloid leukemia minimal residual disease assessment searched by serum peptidome profiling.Gene Expression of VEGF-A and VEGF-C in Peripheral Blood Mononuclear Cells of Iranian Patients with Acute Myeloid Leukemia.Epigenetic dysregulation of NKD2 is a valuable predictor assessing treatment outcome in acute myeloid leukemia.Analysis of Chromosomal Aberrations and FLT3 gene Mutations in Childhood Acute Myelogenous Leukemia Patients.1,3-Butadiene: III. Assessing carcinogenic modes of action.Targeting PI3K in Cancer: Any Good News?Targeting PI3K/AKT/mTOR network for treatment of leukemia.RKTG overexpression inhibits proliferation and induces apoptosis of human leukemia cells via suppression of the ERK and PI3K/AKT signaling pathwaysLow NKD1 expression predicts adverse prognosis in cytogenetically normal acute myeloid leukemia.High-Level Expression, Purification and Large-Scale Production of l-Methionine γ-Lyase from Idiomarina as a Novel Anti-Leukemic Drug.shRNA-mediated EMMPRIN silencing inhibits human leukemic monocyte lymphoma U937 cell proliferation and increases chemosensitivity to adriamycin.Knockdown of RLIP76 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to daunorubicin in U937 leukemia cells.Prognostic and therapeutic relevance of c-FLIP in acute myeloid leukaemia.Depression and hopelessness in patients with acute leukemia: the psychological impact of an acute and life-threatening disorder.shRNA-Mediated BAALC knockdown affects proliferation and apoptosis in human acute myeloid leukemia cells.Assessment of exposure to mixture pollutants in Mexican indigenous children.The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.Bone marrow T-cell percentage: A novel prognostic indicator in acute myeloid leukemia.Pre-treatment blood inflammatory markers as predictors of systemic infection during induction chemotherapy: results of an exploratory study in patients with acute myeloid leukemia.
P2860
Q24594585-8CBC7000-4742-4D7E-91AD-2AA41A28619AQ33231820-B91F6FB1-E079-4E48-A8F3-F948C6AE003EQ33493174-41768EB2-90D0-4EB4-945C-48A408981E51Q33629475-0A9E0896-CBDB-4FFE-A4DF-305FC4F1D69EQ33668436-07EB9C7E-E6F8-4AB7-8E03-9033BAEB354EQ33873323-41CB08A5-C409-4627-9311-E656568469CAQ33914845-EF67156D-280E-42E6-8538-EEDB85746E0CQ34024558-A924E691-FDA8-4269-ADF2-E66757A0B3C8Q34033553-AAB9E45B-5A23-455B-84B6-C43046B21150Q35009275-F2459FF5-78DB-4BE4-B0E0-B8E840D23A6BQ35575464-D7293E5E-896E-49AE-AC54-39D67EA403A7Q35632014-8878444E-6CB9-47FD-BFF2-5B364A941D5DQ35808597-7A7598A0-3C36-4D7A-B14B-01984CB6CBDBQ35835260-56CEFC9B-661C-4787-A8D0-8A5051B98AEFQ35848196-515DF9E9-7288-49C1-A854-4B58785ADB05Q35854158-5AFFF238-CD0A-4652-991E-22B6BD9BAB24Q36153480-28C65925-7FC3-42A5-BC5D-6444C711F420Q36379368-A839B0DD-0922-4C36-ABFF-6615FAA38CFFQ36461618-1458D263-1E51-440D-B86E-07ACDD1011C3Q36738841-E1E6E1CB-FBCA-4782-BE8E-D4FABD806440Q36872102-FC503F30-AF64-4463-B12E-DDC6591BD126Q37114841-388DEBF9-DA30-47B4-95DD-82193B345157Q37426395-017AEA2C-59C1-4BDD-8ECC-A1FB7CA9EEA6Q37675993-1899BB2F-3ACB-4566-943B-3AC0BF961A63Q37702808-11ACB103-9627-4563-9131-B5CD45138238Q37792081-C0455B01-2CBD-43CD-8FD2-AC6663887FBBQ38105322-9B6D5AF6-5DE4-4393-A2BD-90561E9CCB42Q38364871-8CE03D61-2D8C-4C4A-8128-B04BA6AC07CDQ38697666-AACCCB05-A5FB-48E3-BE6C-94FD35DCF431Q38819676-CD385CD8-C43E-4589-9E1C-3B0D1D8AFB20Q38840733-6A96ACD8-5BC0-4BAD-A20C-320F6FD3EDBEQ38953034-FF537558-B2CC-4CEE-8010-2B7DD903925DQ38993967-1E689623-8F66-4627-99A5-0F955D68FF21Q39241897-958F8A69-29CB-4933-9D65-50A25E70298FQ39281730-88B936E9-28E0-49DB-BD5B-A5F3203CD048Q39355494-36B7FFB1-7383-445F-9478-4E286A5CD9B1Q40075310-AAF4B652-AD61-4A23-A50A-FAB19096B359Q40162776-79967669-AA91-49E3-9CD3-95F0CD1E9BE9Q40445337-5AF79442-5A9A-4612-8BA5-DA24EDE67387Q41225917-1DB9FC15-25A7-42FD-96D4-597DF18592CB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Adult acute myeloid leukaemia.
@ast
Adult acute myeloid leukaemia.
@en
type
label
Adult acute myeloid leukaemia.
@ast
Adult acute myeloid leukaemia.
@en
prefLabel
Adult acute myeloid leukaemia.
@ast
Adult acute myeloid leukaemia.
@en
P2093
P1476
Adult acute myeloid leukaemia
@en
P2093
Carlo Tondini
Matthew Smith
Michael Barnett
Renato Bassan
Wolfgang Kern
P304
P356
10.1016/J.CRITREVONC.2003.11.002
P50
P577
2004-06-01T00:00:00Z